Who Owns Chemed Company?

Chemed Bundle

Get Full Bundle:

	SWOT	$15	$10
	5 FORCES	$15	$10
	BCG	$15	$10
	CANVAS	$15	$10
	4P's MIX	$15	$10
	PESTLE	$15	$10

TOTAL:

ADD TO CART

Who Really Calls the Shots at Chemed Company?

Understanding the ownership structure of a company is crucial for any investor or business strategist. Chemed Company, a diversified firm with a significant presence in both healthcare and services, offers a compelling case study. Its strategic decisions, from acquisitions like VITAS Healthcare to its enduring success, are deeply intertwined with its ownership dynamics.

Founded in 1970, Chemed's journey, including its strategic acquisition of VITAS Healthcare in 2004, showcases how ownership impacts a company's growth. With a market capitalization of approximately $8.23 billion as of June 2025, understanding the Chemed SWOT Analysis and the influence of key stakeholders on Chemed ownership and Chemed stock is essential. This analysis explores the evolution of Chemed Company's ownership, from its founding to its current structure, examining the roles of major investors and the impact of its subsidiaries like Roto-Rooter.

The story of the Chemed Company begins with its incorporation in Delaware in 1970. Initially, it was a subsidiary of W.R. Grace & Co., taking over the Special Products Group as of April 30, 1971. This structure set the stage for Chemed's development, guiding its early operations and strategic direction.

The roots of Chemed extend further back to the DuBois Soap Company, established in June 1920 by T.V. DuBois. This company, which produced soap chips and powders, later expanded into industrial cleaning products. In 1964, W.R. Grace acquired DuBois Soap Company, renaming it the DuBois Chemicals Division. Another key part of Chemed, Roto-Rooter, founded in 1936, was acquired by Chemed in 1980.

While the specific ownership details at Chemed's inception are not publicly available, its formation as a subsidiary of W.R. Grace & Co. indicates that W.R. Grace held the majority stake. This setup allowed Chemed to develop its own products. Early agreements were likely managed internally by W.R. Grace before Chemed became an independent public entity.

Key Ownership Details

Understanding the early ownership of Chemed is crucial to understanding its growth. The company's initial structure as a subsidiary of W.R. Grace & Co. provided a foundation for its future. The acquisition of Roto-Rooter in 1980 was a significant step in Chemed's expansion.

• Chemed was incorporated in 1970 as a subsidiary of W.R. Grace & Co.
• DuBois Soap Company, founded in 1920, was acquired by W.R. Grace in 1964.
• Roto-Rooter, founded in 1936, was acquired by Chemed in 1980.
• Chemed remained a subsidiary until March 10, 1982.

Chemed SWOT Analysis

• Complete SWOT Breakdown
• Fully Customizable
• Editable in Excel & Word
• Professional Formatting
• Investor-Ready Format

GET TEMPLATE ➔

The ownership of the Chemed Company, a publicly traded entity on the New York Stock Exchange under the ticker symbol CHE, is primarily held by institutional investors. This structure has evolved over time, with a notable shift towards increased institutional ownership. This trend reflects broader market dynamics where institutional investors play a significant role in the governance and strategic direction of publicly listed companies. The evolution of Chemed's ownership structure is a key factor in understanding its corporate strategy and financial performance.

As of March 2025, institutional investors control approximately 94.41% of Chemed's stock. This concentration indicates a strong influence from large investment firms, mutual funds, and index funds. The increasing presence of institutional investors has shaped the company's approach to shareholder value and long-term growth strategies. The company's history, including its association with subsidiaries like Roto-Rooter, has also influenced its investor profile.

Key institutional shareholders include Vanguard Group Inc., holding 11.3% of the shares, which equates to approximately $928.8 million. BlackRock, Inc. holds 8.875% of the shares. These large holdings give these institutions significant influence over company decisions. Retail and individual investors hold a smaller percentage of the company's stock. Understanding the Chemed ownership structure is crucial for anyone looking to invest in Chemed stock and assess the company's long-term prospects.

Key Takeaways on Chemed Ownership

The majority of Chemed Company is owned by institutional investors, signaling stability and long-term focus.

• Vanguard and BlackRock are the largest institutional shareholders.
• Institutional ownership influences company strategy and governance.
• Retail investors hold a smaller portion of the stock.
• For more information on the company's structure, you can refer to this article on 0.

Chemed PESTLE Analysis

• Covers All 6 PESTLE Categories
• No Research Needed – Save Hours of Work
• Built by Experts, Trusted by Consultants
• Instant Download, Ready to Use
• 100% Editable, Fully Customizable

GET TEMPLATE ➔

As of May 19, 2025, the board of directors for Chemed Company comprised nine members. These directors include Kevin J. McNamara, who also serves as Chairman and CEO, Ron DeLyons, Patrick P. Grace, Christopher J. Heaney, Thomas C. Hutton, Andrea R. Lindell, Elaine McCarthy, John M. Mount Jr., and George J. Walsh III. McNamara has been with the company for over three decades, bringing extensive experience to the leadership role. The board's composition reflects a mix of expertise aimed at guiding Chemed's strategic direction and ensuring effective governance.

The board members' roles are critical in overseeing the company's performance. The election of directors at the annual meeting on May 19, 2025, saw substantial support for each nominee, with votes ranging from 10,511,691 to 12,957,467 in favor. This strong endorsement underscores the shareholders' confidence in the current leadership. The board's responsibilities include setting strategic goals and monitoring financial outcomes, ensuring the company operates in the best interests of its shareholders.

Chemed Company's voting structure follows a one-share-one-vote system, with each share of capital stock entitled to one vote. There are no indications of special voting rights or dual-class shares that would grant disproportionate control to specific individuals or entities. Recent actions by the board include the approval of the 2025 Stock Incentive Plan and the ratification of PricewaterhouseCoopers LLP as the independent accountants for 2024. For more information on the company's strategy, check out the Growth Strategy of Chemed.

Voting Power and Board Oversight

The board of directors at Chemed Company plays a vital role in governance, with each director's election reflecting shareholder confidence. The voting structure ensures that all shareholders have equal voting rights. The board's actions directly influence the company's strategic direction and financial performance.

• The board consists of nine elected directors as of May 19, 2025.
• The voting structure is one-share-one-vote.
• The board oversees strategic direction and financial performance.
• The 2025 Stock Incentive Plan was approved.

Chemed Business Model Canvas

• Complete 9-Block Business Model Canvas
• Effortlessly Communicate Your Business Strategy
• Investor-Ready BMC Format
• 100% Editable and Customizable
• Clear and Structured Layout

GET TEMPLATE ➔

Over the past few years, Chemed Company has actively managed its capital and pursued strategic growth initiatives. In late 2024, the company repurchased a significant number of its own shares, demonstrating a commitment to returning value to shareholders. The company's board also authorized additional funds for future stock repurchases, signaling confidence in its financial stability and future prospects. These actions can influence the price.

In early 2025, Chemed continued its growth trajectory through acquisitions. VITAS Healthcare, a subsidiary, expanded its operations, which contributed to revenue increases. The company's financial performance, including revenue growth in both VITAS Healthcare and Roto-Rooter, reflects its strategic expansion and market positioning. structure also plays a crucial role in its financial stability.

Institutional investors hold a substantial portion of Chemed's stock, representing approximately 95.85% as of June 2025. Insider ownership is relatively small, with insiders owning 3.29% of the company's stock as of June 2025. There have been no major announcements regarding changes in the ownership structure or significant departures that would alter the current ownership dynamics.

Share Repurchases

Chemed's share repurchase program in late 2024 and early 2025 demonstrates a strategy to return value to shareholders. These buybacks can reduce the number of outstanding shares and potentially increase earnings per share.

Acquisition Strategy

VITAS Healthcare's acquisition of Covenant Health's hospice assets and the growth in VITAS's net patient revenue indicate a focus on expanding the company's service offerings and market presence.

Institutional Ownership

The high percentage of institutional ownership reflects the confidence of large investors in Chemed's business model and financial performance, signaling stability and trust.

Insider Ownership

Relatively small insider ownership suggests that while the management team is aligned with the company's success, the majority of the stock is held by external investors.

Chemed Porter's Five Forces Analysis

• Covers All 5 Competitive Forces in Detail
• Structured for Consultants, Students, and Founders
• 100% Editable in Microsoft Word & Excel
• Instant Digital Download – Use Immediately
• Compatible with Mac & PC – Fully Unlocked

GET TEMPLATE ➔

Related Blogs